Based on critical analyses of the costs of drugs in Canada, researchers from six universities, including Carleton’s M-A. Gagnon, released their report Pharmacare2020 —The Future of Drug Coverage in Canada. An editorial in the Toronto Star notes that the best reason for a national pharmacare plan is “about giving all Canadians fair and equitable access to medicines they need — drugs that work to keep them healthy, ease their pain, and save their lives”.
Home / Recent Releases / The Future of Drug Coverage in Canada
The Future of Drug Coverage in Canada